.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Baxter
Fish and Richardson
Accenture
Harvard Business School
Medtronic
Colorcon
QuintilesIMS
McKinsey
UBS

Generated: July 23, 2017

DrugPatentWatch Database Preview

Glyburide - Generic Drug Details

« Back to Dashboard

What are the generic sources for glyburide and what is the scope of glyburide patent protection?

Glyburide
is the generic ingredient in seven branded drugs marketed by Sanofi Aventis Us, Aurobindo Pharma, Heritage Pharms Inc, Actavis Elizabeth, Zydus Pharms Usa Inc, Pharmacia And Upjohn, Epic Pharma Llc, Sandoz, Impax Labs Inc, Pharmadax Inc, Teva, Hikma, Dava Pharms Inc, Mylan, and Bristol Myers Squibb, and is included in twenty-five NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for glyburide. Forty-four suppliers are listed for this compound.

Summary for Generic Name: glyburide

Tradenames:7
Patents:2
Applicants:15
NDAs:25
Drug Master File Entries: see list20
Suppliers / Packagers: see list44
Bulk Api Vendors: see list84
Clinical Trials: see list61
Patent Applications: see list6,286
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:glyburide at DailyMed

Pharmacology for Ingredient: glyburide

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
GLYBURIDE (MICRONIZED)
glyburide
TABLET;ORAL074686-001Apr 20, 1999ABRXNoNo► Subscribe► Subscribe
Zydus Pharms Usa Inc
GLYBURIDE
glyburide
TABLET;ORAL206749-001May 10, 2016AB1RXNoNo► Subscribe► Subscribe
Hikma
GLYBURIDE (MICRONIZED)
glyburide
TABLET;ORAL075890-002Jul 31, 2003ABRXNoNo► Subscribe► Subscribe
Impax Labs Inc
GLYBURIDE
glyburide
TABLET;ORAL206079-002Sep 30, 2015AB2RXNoNo► Subscribe► Subscribe
Bristol Myers Squibb
GLUCOVANCE
glyburide; metformin hydrochloride
TABLET;ORAL021178-003Jul 31, 2000ABRXYesNo6,303,146*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: glyburide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
DIABETA
glyburide
TABLET;ORAL017532-003May 1, 19843,454,635► Subscribe
Pharmacia And Upjohn
MICRONASE
glyburide
TABLET;ORAL017498-002May 1, 19843,426,067► Subscribe
Pharmacia And Upjohn
GLYNASE
glyburide
TABLET;ORAL020051-001Mar 4, 19924,735,805► Subscribe
Pharmacia And Upjohn
GLYNASE
glyburide
TABLET;ORAL020051-004Sep 24, 19934,735,805► Subscribe
Pharmacia And Upjohn
MICRONASE
glyburide
TABLET;ORAL017498-002May 1, 19843,507,954► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Covington
Daiichi Sankyo
Fish and Richardson
Queensland Health
McKinsey
UBS
Deloitte
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot